Evoke Pharma (EVOK) Return on Equity (ROE) (2013 - 2025)
Evoke Pharma (EVOK) Return on Equity (ROE) from Sep 30, 2013 to Sep 30, 2025. The TTM Evoke Pharma (EVOK) Return on Equity (ROE) is -34.39%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Evoke Pharma (EVOK)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2024 | -75.99% | -125.17% |
| 2023 | 301.94% | N/A |
| 2023 | 301.94% | -330.26% |
| 2022 | -131.13% | -34.91% |
| 2022 | -201.47% | -16.01% |
| 2021 | -239.89% | -158.56% |
| 2020 | 409.66% | -351.65% |
| 2019 | -162.79% | -13.34% |
| 2018 | -187.84% | -66.67% |
| 2017 | -563.59% | +98.70% |
| 2016 | -283.64% | -19.03% |
| 2015 | -350.29% | +142.96% |
| 2014 | -144.18% | +975.25% |
| 2013 | -13.41% | -230.50% |
| 2012 | 10.27% | -24.44% |
| 2011 | 13.60% | -58.78% |
| 2010 | 32.98% | -34.29% |
| 2009 | 50.19% | -20.28% |
| 2008 | 62.96% | -39.86% |
| 2007 | 104.69% | N/A |